In a regulatory 8K filing, the company states: “On September 12, 2023, members of CVS Health Corporation’s senior management team will meet with investors and will participate in a webcast at 8:50 a.m. During the meetings and webcast, the senior management team will reaffirm the Company’s previously announced full year 2023 GAAP diluted earnings per share guidance range of $6.53 to $6.75, its full year 2023 Adjusted EPS guidance range of $8.50 to $8.70 and its full year 2023 cash flow from operations guidance range of $12.5 billion to $13.5 billion.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CVS:
- Mixed Day for CVS Health (NYSE:CVS) amid Upgrades and Warning Letters
- 3 Best Stocks to Buy Now, 9/12/2023, According to Top Analysts
- Wolfe believes CVS can get back to 4 STARs on large PPO contract for 2025
- Health Insurers make thousands on marking up generic drugs, WSJ says
- Walmart (NYSE:WMT) Eyes Health Care Sector with Massive Investment